Correlation of matrix metalloproteinase-2 single nucleotide polymorphisms with the risk of small vessel disease (SVD)
- 9 May 2015
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 356 (1-2) , 61-64
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of China (30870847, 30870848, 81171099)
- Science and Technology Program Project in Bao'an Dictrict, Shenzhen (2010618)
This publication has 27 references indexed in Scilit:
- Matrix metalloproteinase‐2 polymorphisms and clinical outcome of Chinese patients with nonsmall cell lung cancer treated with first‐line, platinum‐based chemotherapyCancer, 2011
- Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian populationBiomarkers, 2011
- Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challengesThe Lancet Neurology, 2010
- Early activation of matrix metalloproteinase-9 is associated with blood–brain barrier disruption after photothrombotic cerebral ischemia in ratsActa Neurochirurgica, 2009
- Living Beyond Our Physiological MeansStroke, 2009
- Matrix Metalloproteinase-2 Plays a Critical Role in the Pathogenesis of White Matter Lesions After Chronic Cerebral Hypoperfusion in RodentsStroke, 2006
- Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?Stroke, 2003
- Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosisBrain, 2003
- Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 GeneJournal of Biological Chemistry, 2001
- Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary AtherosclerosisCirculation, 1999